Certara collaborates with korea institute of toxicology to ensure fda submission-ready send dataset

Seoul, south korea--(business wire)--certara, inc. (nasdaq: cert), a global leader in biosimulation, today announced that a korea institute of toxicology (kit) have decided to implement certara's pinnacle 21 enterprise data conformance and submission software and send explorer pre-clinical data visualization software . the combination of pinnacle 21 enterprise and send explorer enables synergy for meeting global regulatory guidelines and delivering efficiency. the technology optimizes data anal.
CERT Ratings Summary
CERT Quant Ranking